Home ›› Cancer Programs ›› Research & Publications

2013

Lectures Presented (to date):

  • February 20th, 2013: Round table discussion regarding gene expression profiling and G-Cimp evaluation for gliomas (Castlebiosciences). Del Frisco’s, Orlando, Florida.
  • February 23rd, 2013: Neuro-Oncology discussion at Sarah Cannon Research Institute Annual Scientific Meeting. Nashville Downtown Hilton hotel, TN.
  • Presented at the Genentech Advisory Board Meeting, San Francisco, Intercontinental Hotel, March 2013.
  • March 9th, 2013: Malignant Gliomas: An Update. Florida Brain Tumor Association(FBTA) Annual meeting. West Palm Beach, Florida.
  • March 9th, 2013: Mock Tumor Board Presentation. Florida Brain Tumor Association(FBTA) Annual meeting. West Palm Beach, Florida.
  • Presented Gliadel to the Mexican FDA, April 2013
  • High Grade Glioma Management  Presentation and Discussion, Gliadel Advisory Board Meeting, July 19th and the 20th, Chicago, IL.
Back to Top

2012

Lectures Presented:

  • January 12th, 2012: Current Concepts in Glioblastoma Management: Oncology Grand Rounds, Tampa, Florida.
  • March 14th, 2012: Malignant Glioma Management: Oncology Lecture, Café Margeaux, Cocoa Beach, Fl.
  • March 28th, 2012: Leptomeningeal Metastases, A Review, Oncology Noon Rounds, South Carolina Oncology Associates, Columbia, SC.
  • June 20th, 2012: Current Concepts of Leptomeningeal metastases. Oncology Grand Rounds, Charlotte, NC.
  • November 16th, 2012: Molecular genetic testing and therapeutic decisions in Glioblastoma. Society for Neuro-Oncology (SNO) Annual Meeting. Washington DC.
  • December 7th, 2012: Antiangiogenesis and Glioblastoma. Intercontinental Hotel, San Francisco, CA.
  • December 18th, 2012: RECOTHROM and immune mediated coagulopathy. Ruth Chris Steak House, Fort Lauderdale, Fl.

 Meetings Attended and Advised at:

  • Sarah Canon Research Institute Scientific Meeting, March 2012, Nashville, TN
  • Society for Neuro-Oncology Annual Scientific Meeting, November 2012, Washington, DC
  • High Grade Glioma Management and Gliadel Advisory Board Meeting
  • Anti-angiogenesis, Bevacizumab and Genentech Advisory Board Meeting

 Abstracts / Posters Submitted and Accepted:

  • Chowdhary, S.1, Given, B.2,Given, C.W. 2,  Majeske, C.2, Decker, V.3, Decker, P.3, Decker, B.3 Small Business Technology Transfer (STTR) Phase 1 Study of an Automated Voice Response (AVR) system to improve symptom management in Neuro-Oncology Patients (Submitted and accepted as an abstract / poster to ASCO 2012 Chicago).
  •  A Phase II Trial of the Combination of Bevacizumab and Everolimus in Patients with Refractory, Progressive Intracranial Meningioma, Shih K, Chowdhary S et al. Society for Neuro-Oncology Annual Scientific Meeting, November 2012, Washington DC. 

Publications:

Back to Top